Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European Union

This multicenter, observational drug utilization (DU) study (NCT01594996) investigated the profile of patients and specialist providers who prescribed extended release quetiapine fumarate (quetiapine XR) for treatment of major depressive disorder (MDD) across five European countries (Germany, Italy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Brody, Robert S., Liss, Charles L., Wray, Heather, Kastango, Kari, Bryant, Allison, Fabre, Alban, Thuresson, Anneli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805122/
https://www.ncbi.nlm.nih.gov/pubmed/29068794
http://dx.doi.org/10.1097/YIC.0000000000000202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805122/
https://www.ncbi.nlm.nih.gov/pubmed/29068794
http://dx.doi.org/10.1097/YIC.0000000000000202

Ejemplares similares